Sarepta Therapeutics

YTD

ALL

Trade Sarepta Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About SRPT

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

CEO

Douglas S. Ingram

CEODouglas S. Ingram

Employees

1,372

Employees1,372

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

1980

Founded1980

Employees

1,372

Employees1,372

SRPT Key Statistics

Market cap

1.79B

Market cap1.79B

Price-Earnings ratio

-24.03

Price-Earnings ratio-24.03

Dividend yield

—

Dividend yield—

Average volume

22.32M

Average volume22.32M

High today

$19.05

High today$19.05

Low today

$17.62

Low today$17.62

Open price

$18.12

Open price$18.12

Volume

10.42M

Volume10.42M

52 Week high

$144.22

52 Week high$144.22

52 Week low

$10.42

52 Week low$10.42

SRPT News

Seeking Alpha 2d

Sarepta rises on strong quarterly earnings and revenue

Shares of Sarepta Therapeutics (NASDAQ:SRPT) rose on Wednesday after the market as it reported second quarter revenue and profit above expectations. The compan...

Seeking Alpha 2d

Sarepta reportedly hired Trump-linked lobbying firm after gene therapy deaths

Healthcare Sarepta reportedly hired Trump-linked lobbying firm after gene therapy deaths Aug. 06, 2025 3:05 PM ET Sarepta Therapeutics, Inc. (SRPT) Stock RHHBY,...

Analyst ratings

62%

of 29 ratings

Buy

20.7%

Hold

62.1%

Sell

17.2%

People also own

Based on the portfolios of people who own SRPT. This list is generated using Robinhood data, and it’s not a recommendation.

Opendoor Technologies